Predictive value of silent myocardial ischemia for cardiac events in diabetic patients: Influence of age in a French multicenter study

Diabetes Care

Volumn 28, Issue 11, 2005, Pages 2722-2727

  Valensi, Paul ^a   Pariès, Jacques ^a   Brulport Cerisier, Valérie ^b   Torremocha, Florence ^c   Sachs, Régis Nessim ^a   Vanzetto, Gérald ^d   Cosson, Emmanuel ^a   Lormeau, Boris ^a   Attali, Jean Raymond ^a   Maréchaud, Richard ^c   Estour, Bruno ^b   Halimi, Serge ^d  

^a HÔPITAL JEAN VERDIER   (France)

^b UNIVERSITY HOSPITAL OF SAINT ETIENNE   (France)

^c POITIERS UNIVERSITY HOSPITAL   (France)

^d GRENOBLE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DIPYRIDAMOLE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; THALLIUM 201; TRIACYLGLYCEROL; DIAGNOSTIC AGENT; THALLIUM; VASODILATOR AGENT;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; EXERCISE ELECTROCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART DEATH; HEART FAILURE; HEART INFARCTION; HEART MUSCLE PERFUSION; HEART MUSCLE REVASCULARIZATION; HOSPITAL DEPARTMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INVASIVE PROCEDURE; PREDICTION; PREVALENCE; SILENT MYOCARDIAL ISCHEMIA; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STRESS; TRIACYLGLYCEROL BLOOD LEVEL; UNSTABLE ANGINA PECTORIS; AGING; ALGORITHM; BLOOD; CHI SQUARE DISTRIBUTION; COMPARATIVE STUDY; DIABETIC NEPHROPATHY; DIET RESTRICTION; EXERCISE TEST; FRANCE; HEART MUSCLE ISCHEMIA; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY; PREDICTION AND FORECASTING; RISK; RISK FACTOR; SCINTISCANNING; SURVIVAL;

AGING; ALGORITHMS; CHI-SQUARE DISTRIBUTION; CHOLESTEROL, HDL; COHORT STUDIES; DIABETES MELLITUS; DIABETIC NEPHROPATHIES; DIPYRIDAMOLE; EXERCISE TEST; FASTING; FEMALE; FOLLOW-UP STUDIES; FRANCE; HUMANS; MALE; MIDDLE AGED; MULTICENTER STUDIES; MYOCARDIAL ISCHEMIA; ODDS RATIO; PREDICTIVE VALUE OF TESTS; PREVALENCE; RISK FACTORS; SURVIVAL ANALYSIS; THALLIUM RADIOISOTOPES; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TRIGLYCERIDES; VASODILATOR AGENTS;

EID: 33644787708     PISSN: 01495992     EISSN: 01495992     Source Type: Journal    
DOI: 10.2337/diacare.28.11.2722     Document Type: Article

References (29)

1. Cohn PF: Should silent ischemia be treated in asymptomatic individuals? Circulation 82 (Suppl. II):149-154, 1990
2. Erikssen J: Prognostic importance of silent ischemia during long-term follow-up of patients with coronary artery disease: a short review based on own experience and current literature. Herz 12:359-368, 1987
3. Gordon DJ, Ekelund LG, Karon JM, Probstfield JL, Rubenstein C, Sheffield LT, Weissfeld L: Predictive value of the exercise test for mortality in North American men: the Lipid Research Clinics Mortality Follow-up study. Circulation 72:252-261, 1986
4. Josephson RA, Shefrin E, Lakatta EG, Brant LJ, Fleg JL: Can serial exercise testing improve the prediction of coronary events in asymptomatic individuals? Circulation 81:20-24, 1990
5. Gottlieb SO, Weisfeld ML, Ouyang P, Mellits ED, Gertenblith G: Silent ischemia predicts infarction and death during two year follow-up of unstable angina. J Am Coll Cardiol 10:756-760, 1987
6. Mulcahi D, Parmeshwar J, Holdright D Wright C, Sparrow J, Sutton G, Fox KM: Value of ambulatory ST segment monitoring in patients with chronic stable angina: does measurement of the "total ischaemic burden" assist with management? Br Heart J 67:47-52, 1992
7. Koistinen MJ: Prevalence of asymptomatic myocardial ischemia in diabetic patients. Br Med J 301:92-95, 1990
8. Milan Study on Atherosclerosis and Diabetes (MiSAD) Group: Prevalence of unrecognized silent myocardial ischemia and its association with atherosclerotic risk factors in non insulin-dependent diabetes mellitus. Am J Cardiol 79:134-139, 1997
9. Valensi P, Sachs R: N, Lormeau B, Taupin JM, Ouzan J, Blasco A, Nitenberg A, Metz D, Pariès J, Talvard O, Leutenegger M, Attali JR: Silent myocardial ischaemia and left ventricle hypertrophy in diabetic patients Diabete Metab 23:409-416, 1997
10. Janand-Delenne B, Savin B, Habib G, Bory M, Vague P, Lassmann-Vague V: Silent myocardial ischemia in patients with diabetes: who to screen. Diabetes Care 22:1396-1400, 1999
11. Cosson E, Paycha F, Pariès J, Cattan S, Ramadan A, Meddah D, Attali JR, Valensi P: Detecting silent coronary stenoses and stratifying cardiac risk in patients with diabetes: ECG stress test or exercise myocardial scintigraphy? Diabet Med 21:342-348, 2004
12. Gazzaruso C, Garzaniti A, Giordanetti S, Falcone C, De Amici E, Geroldi D, Fratino P: Assessment of asymptomatic coronary artery disease in apparently uncomplicated type 2 diabetic patients: a role for lipoprotein(a) and apolipoprotein(a) polymorphism. Diabetes Care 25:1418-1424, 2002
13. Vanzetto G, Halimi S, Hammoud T, Fagret D, Benhamou PY, Cordonnier D, Denis B, Machecourt J: Prediction of cardiovascular events in clinically selected high-risk NIDDM patients: prognostic value of exercise stress test and thallium-201 single-photon emission computed tomography. Diabetes Care 22:19-26, 1999
14. Valensi P, Sachs RN, Harfouche B, Lormeau B, Pariès J, Cosson E, Paycha F, Leutenegger M, Attali JR: Predictive value of cardiac autonomic neuropathy in diabetic patients with or without silent myocardial ischemia. Diabetes Care 24:339-343, 2001
15. Rutter M, Wahid S, McComb J, Marshall S: Significance of silent ischemia and microalbuminuria in predicting coronary events in asymptomatic patients with type 2 diabetes. J Am Coll Cardiol 40:56-61, 2002
16. Faglia E, Favales F, Calia P, Paleari F, Segalini G, Gamba PL, Rocca A, Musacchio N, Mastropasqua A, Testoni G, Rampini P, Moratti F, Braga A, Morabito A: Cardiac events in 735 type 2 diabetic patients who underwent screening for unknown asymptomatic coronary heart disease: 5-year follow-up report from the Milan Study on Atherosclerosis and Diabetes (MiSAD). Diabetes Care 25:2032-2036, 2002
17. Wackers F J Th, Young Lh, Inzucchi SE, Chyun DA, Davey JA, Barrett EJ, Taillefer R, Wittlin SD, Heller GV, Engel S, Ratner RE, Iskandrian AE, the Detection of Ischemia in Asymptomatic Diabetics (DIAD) Investigators: Detection of silent myocardial ischemia in asymptomatic diabetic subjects: the DIAD study. Diabetes Care 27:1954-1961, 2004
18. Miller TD, Rajagopalan N, Hodge DO, Frye RL, Gibbons RJ: Yield of stress single-photon emission computed tomography in asymptomatic patients with diabetes. Am Heart J 147:890-896, 2004
19. Cosson E, Guimfack M, Pariès J, Paycha F, Attali JR, Valensi P: Prognosis for coronary stenoses in patients with diabetes and silent myocardial ischemia. Diabetes Care 26:1313-1314, 2003
20. Nitenberg A, Valensi P, Sachs RN, Dali M, Aptecar M, Attali JR: Impairment of coronary vascular reserve and acetylcholine-induced coronary vasodilation in diabetic patients with normal left ventricular systolic function and angiographically normal coronary arteries. Diabetes 42:1017-1025, 1993
21. Nitenberg A, Valensi P, Sachs R, Cosson E, Attali JR, Antony I: Prognostic value of epicardial coronary artery constriction to the cold pressor test in type 2 diabetic patients with angiographically normal coronary arteries and no other major coronary risk factors. Diabetes Care 27:208-215, 2004
22. Weiner DA, Ryan TJ, Parsons L, Fisher CD, Chaitman BR, Sheffield LT, Tristani FE: Significance of silent myocardial ischemia during exercise testing in patients with diabetes mellitus: a report from the coronary artery surgery study (CASS) registry. Am J Cardiol 68:729-734, 1991
23. Haffner SM, Lehto S, Rönnemaa T, Pyörälä K, Laakso M: Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 339:229-234, 1998
24. Cho E, Rimm EB, Stampfer MJ, Willett WC, Hu FB: The impact of diabetes mellitus and prior myocardial infarction on mortality from all causes and from coronary heart disease in men. J Am Coll Cardiol 40:954-960, 2002
25. Puel J, Valensi P, Vanzetto G, Lassmann-Vague V, Monin JL, Moulin P, Zicarelli C, Mayaudon H, Ovize M, Bernard S, Van Belle E, Halimi S, ALFEDIAM, SFC: Identification of myocardial ischemia in the diabetic patients: joint ALFEDIAM and SFC recommendations (Review). Diabetes Metab 30:3S3-3S18, 2004
26. Pepine CJ, Cohn PF, Deedwania PC, Gibson RS, Handberg E, Hill JA, Miller E, Marks RG, Thadani Y: Effects of treatment on outcome in mildly symptomatic patients with ischemia during daily life: the Atenolol Silent Ischemia Study (ASIST). Circulation 90:762-768, 1994
27. Van Boven AJ, Jukema JW, Zwinderman AH, Crijns HJGM, Lie KI, Bruschke AVG, the REGRESS Study Group: Reduction of transient myocardial ischemia with pravastatin in addition to the conventional treatment in patients with angina pectoris. Circulation 94:1503-1505, 1996
28. Gaede P, Vedel P, Larsen N, Jensen GVH, Parving HH, Pedersen O: Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 348:383-393, 2003
29. Rogers WJ, Bourassa MG, Andrews TC, Bertolet BD, Blumenthal RS, Chaitman BR, Forman SA, Geller NL, Goldberg AD, Habib GB, et al: Asymptomatic Cardiac Ischemia Pilot (ACIP) study: outcome at 1 year for patients with asymptomatic cardiac ischemia randomized to medical therapy or revascularization. J Am Coll Cardiol 26:594-605, 1995